Abstract
The European Network of Gynecological Oncological Trial Groups (ENGOT) is a research network of 17 European academic gynecological cancer trial groups. ENGOT coordinates and promotes clinical trials within Europe in patients with gynecological cancer. In 2010 ENGOT published the requirements for trials between the academic ENGOT and pharmaceutical companies. This has led to a number of new ENGOT trials performed in collaboration with the industry and better coordination of gynecological cancer trials in Europe. Further goals for ENGOT are to increase translational research in ENGOT trials and to develop more trials in cervical cancer, endometrial cancer and in rare gynecological cancers.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
